Apollo Endosurgery, Inc. (APEN)
APENPrice: $10
Fair Value: 🔒
🔒score
Apollo Endosurgery, Inc., a medical technology company, focuses on the design, development, and commercialization of medical devices. The company offers OverStitch and OverStitch Sx Endoscopic Suturing Systems that enable advanced endoscopic procedures by allowing physicians to sutures and secure th... more
Apollo Endosurgery, Inc., a medical technology company, focuses on the design, development, and comm... more
Description
Shares
| Market Cap | $579.72M | Exchange | NASDAQ |
| Sector | Healthcare | Industry | Medical - Devices |
| Country | US | CEO | Charles S. McKhann |
| IPO Date | 2005-04-21 | CAGR | 0.31% |
| Employees | 202 | Website | www.apolloendo.com |
| Div. Yield | — | Payout Ratio | — |
| Buy Back Yield | — | Total Yield | — |
APEN chart loading...
Fundamentals
Technicals
| Enterprise Value | $301.59M | P/E Ratio | -9.43 |
| Forward P/E | — | PEG Ratio | — |
| P/S Ratio | 7.54 | P/B Ratio | 12.47 |
| P/CF Ratio | -13 | P/FCF Ratio | -17.05 |
| EPS | $-1.06 | EPS Growth 1Y | — |
| EPS Growth 3Y | — | EPS Growth 5Y | — |
| Revenue Growth 1Y | 22.01% | Gross Margin | 0.55% |
| Operating Margin | -0.36% | Profit Margin | -0.52% |
| ROE | -0.85% | ROA | -0.36% |
| ROCE | -0.39% | Current Ratio | 2.35 |
| Quick Ratio | 1.89 | Cash Ratio | 1.44 |
| Debt/Equity | 1.75 | Interest Coverage | -5.96 |
| Altman Z Score | 0.74 | Piotroski Score | 3 |